Duke KURe Program

杜克大学KURe计划

基本信息

  • 批准号:
    8588739
  • 负责人:
  • 金额:
    $ 47.46万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-08-01 至 2018-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Benign urological diseases are a major public health concern. Unfortunately, there are insufficient numbers of well-trained cross-disciplinary researchers focused on these conditions. To overcome this limitation, we propose the development of the Duke KURe (K12 Multidisciplinary Urologic Research) Scholars Program. This program would build upon significant institutional support for benign urological research as well as leverage a pre-existing training program while allowing us to provide in-depth research training to a select group of very promising young investigators focused on benign urological diseases. KURe Scholars will undergo an intensive training experience tailored to their individual needs and goals under the guidance of no less than 3 mentors/scholar - one with clinical disease-related expertise, one with research approach-based expertise, and one with biostatistical expertise. Each team of one scholar and three mentors will be assigned a secondary mentor from the mentor pool. The role of the secondary mentor is to provide additional assistance to the scholar, but also to provide "independent" feedback to the primary mentors to ensure coordination and improve the mentoring of the mentors ("teaching the teachers"). Once assembled, these mentoring teams will meet with the scholar no less than quarterly as an entire team. Each scholar will also meet individually with each mentor at least monthly. Scholars will work on research projects designed by the scholar, but under the supervision and guidance of the mentoring team. This team approach is designed to maximize opportunities for the scholars to develop and improve their research skills (clinical, research, and biostatistical), which will maximize scholar education in terms of research design, peer-reviewed publications and future grant opportunities. In addition, all scholars will participate ina year-long course of didactic classes designed specifically for urological researchers. This course already exists at Duke, under the guidance of Dr. Stephen Freedland, PI/PD of the KURe Scholars Program. Beyond the standard year-long course, trainees will have access to classes throughout Duke University to further enhance their educational needs. Indeed, we anticipate all KURe scholars will partake of these extra training opportunities, with many obtaining graduate degrees (e.g. Masters of Clinical Research). The specific goals of the KURe Scholars Program are to: * To recruit and train the next generation of benign urological researchers * 2. Train the next generation of mentors to future benign urological researchers * 3. Improve the overall level of mentoring among research mentors * 4. Share the successful aspects of our KURe Scholars Program with other institutions across the country Our approach to accomplish these goals is outlined in detail in the application. Though the exact number of KURe funded scholars will vary year-to-year based upon availability of scholars, we anticipate that in an idealized setting, we would have 4 KURe funded scholars: 2 junior faculty (MD or MD/PhD), one post- residency fellow (MD or MD/PhD), and one senior post-doctoral researcher (PhD). The Duke KURe program builds on institutional strengths by providing a large and diverse mentoring pool. Indeed, Duke is ideally positioned to train the next generation of leaders in the field of benign urological research. While the initial funding period for the Duke KURe Scholar Program is for 5 years, we are hopeful that through successfully training urological research scholars and helping they achieve future academic success that we will be able to continue our KURe funding indefinitely.
描述(由申请人提供):良性泌尿系统疾病是一个主要的公共卫生问题。不幸的是,专注于这些条件的训练有素的跨学科研究人员数量不足。为了克服这一限制,我们建议开发杜克大学 KURe(K12 多学科泌尿学研究)学者计划。该计划将以对良性泌尿外科研究的重要机构支持为基础,并利用现有的培训计划,同时使我们能够为一组精选的专注于良性泌尿外科疾病的非常有前途的年轻研究人员提供深入的研究培训。 KURe 学者将在不少于 3 名导师/学者的指导下,接受针对个人需求和目标的强化培训体验 - 一名具有临床疾病相关专业知识,一名具有基于研究方法的专业知识,另一名具有生物统计专业知识。每个团队由一名学者和三名导师组成,将从导师库中分配一名二级导师。二级导师的作用是为学者提供额外的帮助,同时也向初级导师提供“独立”的反馈,以确保协调和改进导师的指导(“教导教师”)。一旦组建完毕,这些指导团队将作为整个团队至少每季度与学者会面一次。每位学者还将至少每月与每位导师单独会面。学者将在导师团队的监督和指导下从事由学者设计的研究项目。这种团队方法旨在最大限度地为学者提供发展和提高研究技能(临床、研究和生物统计)的机会,这将最大限度地提高研究设计、同行评审出版物和未来资助机会方面的学者教育。此外,所有学者都将参加专门为泌尿外科研究人员设计的为期一年的教学课程。该课程已在杜克大学开设,由 KURe 学者计划 PI/PD Stephen Freedland 博士指导。除了标准的为期一年的课程外,学员还可以参加杜克大学的课程,以进一步提高他们的教育需求。事实上,我们预计所有 KURe 学者都将参与这些额外的培训机会,其中许多人获得研究生学位(例如临床研究硕士学位)。 KURe 学者计划的具体目标是: * 招募和培训下一代良性泌尿外科研究人员 * 2. 为未来的良性泌尿外科研究人员培养下一代导师 * 3.提高研究导师的整体指导水平 * 4. 与全国其他机构分享我们KURe学者计划的成功经验 申请中详细概述了我们实现这些目标的方法。尽管 KURe 资助的学者的确切数量每年都会根据学者的数量而有所不同,但我们预计在理想的情况下,我们将有 4 名 KURe 资助的学者:2 名初级教师(MD 或 MD/PhD)、1 名住院医师后研究员(MD 或 MD/PhD)和 1 名高级博士后研究员(PhD)。杜克大学 KURe 项目通过提供庞大且多样化的指导池来建立机构优势。事实上,杜克大学处于培养良性泌尿学研究领域下一代领导者的理想位置。虽然杜克大学 KURe 学者计划的初始资助期限为 5 年,但我们希望通过成功培训泌尿外科研究学者并帮助他们取得未来的学术成功,我们将能够无限期地继续提供 KURe 资助。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Stephen Jay Freedland其他文献

Stephen Jay Freedland的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Stephen Jay Freedland', 18)}}的其他基金

A randomized controlled phase 2 study of the ketogenic diet for patients with newly diagnosed glioblastoma in combination with standard-of-care treatment
一项针对新诊断胶质母细胞瘤患者的生酮饮食与标准护理治疗相结合的随机对照 2 期研究
  • 批准号:
    10568656
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
KUH-ART: Advanced Research Training in Kidney disease, Urology and Hematology
KUH-ART:肾脏疾病、泌尿科和血液学高级研究培训
  • 批准号:
    10657816
  • 财政年份:
    2021
  • 资助金额:
    $ 47.46万
  • 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
  • 批准号:
    10381279
  • 财政年份:
    2021
  • 资助金额:
    $ 47.46万
  • 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
  • 批准号:
    9889065
  • 财政年份:
    2018
  • 资助金额:
    $ 47.46万
  • 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
  • 批准号:
    10116314
  • 财政年份:
    2018
  • 资助金额:
    $ 47.46万
  • 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
  • 批准号:
    10376281
  • 财政年份:
    2018
  • 资助金额:
    $ 47.46万
  • 项目类别:
Racial Differences in Prostate Cancer Molecular Subtyping
前列腺癌分子亚型的种族差异
  • 批准号:
    10524093
  • 财政年份:
    2018
  • 资助金额:
    $ 47.46万
  • 项目类别:
Duke KURe Program
杜克大学KURe计划
  • 批准号:
    8703852
  • 财政年份:
    2013
  • 资助金额:
    $ 47.46万
  • 项目类别:
Midcareer Investigator Award
职业生涯中期研究员奖
  • 批准号:
    8699162
  • 财政年份:
    2012
  • 资助金额:
    $ 47.46万
  • 项目类别:
Midcareer Investigator Award
职业生涯中期研究员奖
  • 批准号:
    8531887
  • 财政年份:
    2012
  • 资助金额:
    $ 47.46万
  • 项目类别:

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

FAIRClinical: FAIR-ification of Supplementary Data to Support Clinical Research
FAIRClinical:补充数据的 FAIR 化以支持临床研究
  • 批准号:
    EP/Y036395/1
  • 财政年份:
    2024
  • 资助金额:
    $ 47.46万
  • 项目类别:
    Research Grant
Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention
优化兽医临床研究结果与人类健康系统的整合,以改进早期检测和干预策略
  • 批准号:
    10764456
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
The IDeA State Consortium for a Clinical Research Resource Center: Increasing Clinical Trials in IDeA States through Communication of Opportunities, Effective Marketing, and WorkforceDevelopment
IDeA 州临床研究资源中心联盟:通过机会交流、有效营销和劳动力发展增加 IDeA 州的临床试验
  • 批准号:
    10715568
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
The Mayo Clinic NeuroNEXT Clinical Research Site
梅奥诊所 NeuroNEXT 临床研究网站
  • 批准号:
    10743328
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
Addressing Underperformance in Clinical Trial Enrollments: Development of a Clinical Trial Toolkit and Expansion of the Clinical Research Footprint
解决临床试验注册表现不佳的问题:开发临床试验工具包并扩大临床研究足迹
  • 批准号:
    10638813
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
Improving Multicultural Engagement in Clinical Research through Partnership with Federally Qualified Health Centers and Community Health Worker Programs
通过与联邦合格的健康中心和社区卫生工作者计划合作,改善临床研究中的多元文化参与
  • 批准号:
    10823828
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
The Minnesota TMD IMPACT Collaborative: Integrating Basic/Clinical Research Efforts and Training to Improve Clinical Care
明尼苏达州 TMD IMPACT 协作:整合基础/临床研究工作和培训以改善临床护理
  • 批准号:
    10828665
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
Promoting a Culture Of Innovation, Mentorship, Diversity and Opportunity in NCI Sponsored Clinical Research: NCI Research Specialist (Clinician Scientist) Award Application of Janice M. Mehnert, M.D.
在 NCI 资助的临床研究中促进创新、指导、多样性和机会文化:Janice M. Mehnert 医学博士的 NCI 研究专家(临床科学家)奖申请
  • 批准号:
    10721095
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
Clinical Research Center for REstoration of NEural-based Function in the Real World (RENEW)
现实世界神经功能恢复临床研究中心 (RENEW)
  • 批准号:
    10795328
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
Mentoring Scientists for Careers in HIV Translational Clinical Research
指导科学家从事艾滋病毒转化临床研究
  • 批准号:
    10762827
  • 财政年份:
    2023
  • 资助金额:
    $ 47.46万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了